She worked in PWC and Deloitte & Touch Corporate Finance and was responsible for many large enterprises and investment fund M&A projects.

Lanchun joined Cathay Capital in 2010, bringing deep understanding of industry trends and investment direction, and leading the team to invest in several high quality companies, including Meinian Health (002044.SZ), Poten Environment (603603.SH), Pinduoduo (PDD.NYSE), Shenghuo Pharmaceutical, Righton Bio, Cabio, Soocas, Lumi, Ifchange, Magmode, Momenta, Meet You, Brass Master, UShopal and Arsmo and more.